| Financial Year |
March 31 2023 |
| Monetary Funds |
53,382,650.27 |
| Held-for-trading Financial Assets |
191,317,445.24 |
| Notes Receivable |
11,004,988.24 |
| Accounts Receivable |
136,771,365.25 |
| Advances to Suppliers |
6,375,440.55 |
| Other Receivables |
13,781,376.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
171,327,096.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,587,798.82 |
| Total Current Assets |
622,557,200.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
298,284,638.81 |
| Under-construction Projects |
33,903,899.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,596,843.91 |
| R&D expenses |
-- |
| Goodwill |
47,778,184.41 |
| Long-Term Deferred and Prepaid Expenses |
4,350,275.25 |
| Deferred Income Tax Assets |
4,329,236.54 |
| Other Non-Current Assets |
36,384,425.73 |
| Sub-Total of Non-Current Assets |
494,726,436.33 |
| Total Assets |
1,117,283,636.50 |
| Short-Term Loans |
75,052,004.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
108,813,936.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,805,249.39 |
| Taxes Payable |
2,160,344.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,825,949.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,186,748.30 |
| Other Current Liabilities |
265,276.10 |
| Sub-Total of Current Liabilities |
221,667,977.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
174,317.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,289,064.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,003,252.58 |
| Total Liabilities |
243,671,229.62 |
| Paid-In Capital(Or Share Stock) |
104,163,325.00 |
| Capital Surplus |
503,952,228.63 |
| Surplus Reserve |
35,044,780.91 |
| LESS:Treasury Stock |
15,604,981.00 |
| Undistributed Profits |
190,794,022.05 |
| Minority Stockholder's Interest |
55,263,031.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
818,349,375.59 |
| Owner's Equity（Stockholder's Equity） |
873,612,406.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,117,283,636.50 |
